Cardiovascular Systems (CSII) stock price, revenue, and financials

Cardiovascular Systems market cap is $1.7 b, and annual revenue was $236.55 m in FY 2020

$1.7 B

CSII Mkt cap, 08-Feb-2021

$64.2 M

Cardiovascular Systems Revenue Q2, 2021
Cardiovascular Systems Gross profit (Q2, 2021)50.2 M
Cardiovascular Systems Gross profit margin (Q2, 2021), %78.3%
Cardiovascular Systems Net income (Q2, 2021)-56 K
Cardiovascular Systems EBIT (Q2, 2021)283 K
Cardiovascular Systems Cash, 31-Dec-202073.8 M

Cardiovascular Systems Revenue

Cardiovascular Systems revenue was $236.55 m in FY, 2020

Embed Graph

Cardiovascular Systems Income Statement

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Revenue

18.7m19.7m21.2m23.3m25.3m26.5m29.8m32.3m34.9m41.4m44.7m47.0m43.9m41.4m44.5m49.8m50.0m52.1m49.7m52.6m55.6m56.3m60.2m63.3m64.5m68.3m61.2m64.2m

Cost of goods sold

4.3m4.6m5.1m5.3m6.0m6.2m6.9m7.3m7.7m8.9m9.3m10.4m8.8m8.1m8.7m9.5m9.2m11.1m9.2m9.5m10.0m10.6m11.5m12.2m12.7m13.7m12.2m13.9m

Gross profit

14.3m15.2m16.1m18.0m19.4m20.2m22.9m25.0m27.2m32.5m35.4m36.6m35.1m33.3m35.7m40.3m40.9m41.0m40.5m43.1m45.6m45.7m48.7m51.1m51.8m54.6m49.0m50.2m

Gross profit Margin, %

77%77%76%77%76%76%77%77%78%79%79%78%80%81%80%81%82%79%81%82%82%81%81%81%80%80%80%78%

R&D expense

2.1m3.1m3.0m3.2m4.1m4.0m4.4m5.1m5.4m7.2m8.1m7.8m6.9m7.2m5.7m5.3m5.8m5.4m6.3m6.4m7.3m7.4m7.2m9.3m10.8m10.8m10.0m9.6m

General and administrative expense

15.4m15.7m16.8m20.0m20.4m21.7m25.4m27.5m31.4m33.5m32.6m39.4m41.4m41.3m42.3m36.9m34.0m37.3m35.9m37.0m37.8m41.2m41.1m41.4m46.8m46.9m41.4m40.1m

Operating expense total

17.4m18.8m19.8m23.2m24.5m25.6m29.7m32.5m36.8m40.7m40.6m47.1m48.3m48.5m58.5m42.2m39.8m42.8m42.2m43.4m45.1m48.7m48.3m50.6m57.8m58.0m51.7m50.0m

Depreciation and amortization

234.0k337.0k337.0k304.0k

EBIT

(3.1m)(3.7m)(3.7m)(5.2m)(5.1m)(5.4m)(6.8m)(7.5m)(9.6m)(8.2m)(5.3m)(10.5m)(13.2m)(15.1m)(22.7m)(1.9m)1.1m(1.8m)(1.8m)(275.0k)489.0k(3.0m)384.0k507.0k(5.9m)(3.4m)(2.7m)283.0k

EBIT margin, %

(17%)(19%)(18%)(22%)(20%)(20%)(23%)(23%)(27%)(20%)(12%)(22%)(30%)(37%)(51%)(4%)2%(3%)(4%)(1%)1%(5%)1%1%(9%)(5%)(4%)0%

Interest expense

759.0k476.0k470.0k370.0k345.0k327.0k1.2m119.0k34.0k21.0k113.0k25.0k20.0k10.0k432.0k430.0k429.0k424.0k422.0k420.0k472.0k500.0k501.0k412.0k

Pre tax profit

(1.8m)1.1m(1.7m)(1.9m)(380.0k)398.0k(2.9m)525.0k758.0k(5.7m)(3.4m)(2.8m)7.0k

Income tax expense

24.0k24.0k18.0k33.0k33.0k33.0k33.0k33.0k86.0k38.0k44.0k47.0k63.0k

Net Income

(3.9m)(4.1m)(4.2m)(5.2m)(5.8m)(6.2m)(8.7m)(9.7m)(8.2m)(5.3m)(10.7m)(13.3m)(15.2m)(22.7m)(1.9m)1.0m(1.7m)(2.0m)(413.0k)365.0k(2.9m)492.0k672.0k(5.8m)(3.4m)(2.9m)(56.0k)

Cardiovascular Systems Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

35.5m67.9m126.6m83.8m60.6m107.9m116.3m74.2m185.5m

Accounts Receivable

13.6m14.7m21.4m30.8m23.1m28.5m31.2m36.0m25.2m

Prepaid Expenses

1.5m959.0k1.8m3.4m5.1m3.0m3.3m2.6m

Inventories

7.1m6.2m12.9m14.0m17.4m16.9m16.6m18.1m27.7m

Current Assets

57.8m89.8m162.7m133.9m104.9m159.1m167.6m180.1m287.7m

PP&E

2.2m3.0m15.3m32.9m32.5m29.7m27.7m27.3m27.8m

Total Assets

63.1m96.9m181.9m171.3m142.4m193.9m203.4m218.6m339.5m

Accounts Payable

5.6m7.2m12.7m9.8m8.5m10.7m10.4m11.2m11.5m

Short-term debt

4.7m5.1m2.4m

Current Liabilities

17.9m22.4m29.7m29.9m35.5m41.0m37.5m42.3m44.5m

Long-term debt

12.8m7.5m

Non-Current Liabilities

13.1m7.7m117.0k

Total Debt

17.5m12.6m2.4m

Total Liabilities

30.9m30.1m29.8m31.9m41.5m75.6m68.9m70.6m70.7m

Common Stock

20.0k24.0k31.0k32.0k33.0k33.0k34.0k39.0k

Additional Paid-in Capital

201.8m261.7m390.6m410.7m428.2m447.6m461.9m477.4m631.6m

Retained Earnings

(179.2m)(203.3m)(238.6m)(271.4m)(327.4m)(329.3m)(327.6m)(329.5m)(363.1m)

Total Equity

32.2m66.8m152.1m139.4m100.9m118.4m134.5m147.9m268.8m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

2 x1.4 x1.2 x1.2 x1.4 x1.6 x1.5 x1.5 x1.3 x

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Cash

22.7m24.6m22.5m32.2m29.2m69.9m63.2m146.7m146.0m116.4m101.3m93.5m76.7m65.3m62.2m58.2m79.3m103.1m104.7m107.3m109.3m113.4m118.8m115.3m58.9m65.5m69.6m73.8m

Accounts Receivable

11.8m12.5m13.0m13.5m13.0m15.2m15.3m15.9m19.5m22.4m26.1m31.2m26.9m25.8m23.0m24.3m25.4m27.9m27.3m27.9m31.9m30.3m29.9m35.0m34.6m35.8m30.9m32.5m

Prepaid Expenses

1.2m1.4m980.0k1.2m1.1m778.0k1.5m1.0m3.6m4.1m3.9m2.6m1.6m1.4m2.0m1.4m3.5m6.0m2.6m2.4m2.2m1.9m2.2m2.9m3.0m2.2m3.0m

Inventories

7.1m8.0m7.8m7.0m7.2m6.8m8.3m10.3m11.9m14.6m14.0m13.2m15.4m18.2m18.2m16.9m16.2m16.6m17.0m17.4m17.0m18.1m19.7m19.3m19.5m21.5m24.1m32.5m

Current Assets

42.7m46.4m44.2m53.9m50.5m92.7m88.0m174.3m178.4m157.0m145.4m141.8m123.4m112.8m106.7m102.1m122.9m151.8m155.8m155.8m161.2m164.5m170.7m172.2m161.9m169.7m164.4m293.1m

PP&E

2.3m2.4m2.3m2.1m2.3m2.5m3.0m3.1m3.4m21.2m30.9m32.4m33.7m33.6m33.2m31.8m31.2m30.2m29.2m28.7m28.2m27.4m28.2m27.6m27.4m27.3m27.7m28.1m

Total Assets

48.3m52.0m49.8m60.1m56.6m99.0m95.1m181.0m185.5m182.4m180.6m178.6m162.4m151.2m145.0m138.3m158.7m186.9m190.4m190.1m194.8m200.3m207.2m211.2m217.1m224.2m220.1m348.9m

Accounts Payable

5.2m5.6m5.1m5.6m5.0m6.2m8.5m8.5m11.3m18.2m18.3m17.5m9.8m8.3m8.3m8.8m7.6m8.8m10.7m9.7m9.8m13.0m13.0m12.4m13.1m16.6m13.2m13.7m

Short-term debt

3.9m2.3m3.5m4.7m4.7m4.9m5.1m3.6m1.2m

Current Liabilities

15.1m14.3m16.1m19.3m16.9m20.0m24.0m24.8m29.1m32.0m30.5m33.9m29.9m28.0m35.0m30.5m32.4m38.7m36.3m33.5m36.2m36.3m39.0m40.5m46.9m53.3m50.1m48.1m

Long-term debt

8.4m15.4m14.1m11.6m10.4m8.9m

Non-Current Liabilities

9.9m15.8m14.3m11.8m10.6m9.1m5.9m123.0k112.0k

Total Debt

12.3m17.7m17.5m16.3m15.1m13.8m5.1m3.6m1.2m

Total Liabilities

25.0m30.1m30.5m31.1m27.5m29.0m29.8m24.9m29.2m33.9m32.5m35.9m31.8m30.0m43.2m35.4m46.6m73.4m70.3m66.1m68.3m66.3m68.6m69.6m75.0m80.9m76.9m75.1m

Common Stock

18.0k18.0k18.0k21.0k21.0k24.0k30.0k31.0k31.0k32.0k32.0k32.0k33.0k33.0k33.0k33.0k33.0k33.0k33.0k33.0k33.0k34.0k34.0k34.0k34.0k34.0k39.0k

Additional Paid-in Capital

180.5m182.8m184.5m203.8m210.1m257.5m269.7m371.7m385.2m395.2m400.2m405.3m415.2m421.0m424.2m432.1m440.3m443.4m451.2m455.5m457.6m465.4m469.8m472.5m482.8m487.8m491.1m642.7m

Retained Earnings

(166.3m)(170.4m)(174.6m)(184.4m)(190.2m)(196.4m)(210.6m)(219.2m)(228.9m)(246.8m)(252.1m)(262.7m)(284.6m)(299.8m)(322.5m)(329.3m)(328.3m)(330.1m)(331.3m)(331.7m)(331.3m)(331.4m)(331.3m)(330.9m)(340.8m)(344.6m)(347.9m)(369.0m)

Total Equity

23.3m21.9m19.3m29.0m29.2m70.0m156.1m156.3m148.4m148.2m142.7m130.6m121.3m101.8m102.9m112.1m113.5m120.1m124.0m126.5m134.0m138.6m141.6m142.1m143.3m143.2m273.8m

Debt to Equity Ratio

0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x

Financial Leverage

2.1 x2.4 x2.6 x2.1 x1.9 x1.4 x1.2 x1.2 x1.2 x1.2 x1.3 x1.2 x1.2 x1.4 x1.3 x1.4 x1.6 x1.6 x1.5 x1.5 x1.5 x1.5 x1.5 x1.5 x1.6 x1.5 x1.3 x

Cardiovascular Systems Cash Flow

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021

Net Income

(3.9m)(8.0m)(12.2m)(5.2m)(11.0m)(17.2m)(7.3m)(15.9m)(25.7m)(8.2m)(13.5m)(24.2m)(13.3m)(28.4m)(51.1m)(1.9m)(815.0k)(2.6m)(2.0m)(2.4m)(2.0m)(2.9m)(2.4m)(1.7m)(5.8m)(9.2m)(12.1m)(2.1m)

Depreciation and Amortization

40.0k144.0k293.0k102.0k138.0k408.0k833.0k1.4m973.0k2.0m2.9m1.8m2.8m3.8m1.0m2.1m3.6m854.0k1.7m2.6m974.0k2.1m3.2m2.1m

Accounts Receivable

1.5m824.0k294.0k97.0k494.0k(1.7m)(631.0k)(1.4m)(5.1m)(1.7m)(5.5m)(10.9m)3.8m4.9m7.5m(1.3m)(2.5m)(5.1m)1.1m561.0k(3.6m)855.0k1.2m(3.9m)1.3m(268.0k)4.6m(7.3m)

Inventories

(1.2m)(2.1m)(2.0m)99.0k(100.0k)265.0k(2.0m)(4.0m)(5.6m)(1.8m)(1.1m)(329.0k)(1.5m)(4.3m)(4.3m)553.0k1.3m835.0k(138.0k)(504.0k)(105.0k)(1.5m)(3.1m)(2.7m)(1.4m)(3.4m)(6.0m)(4.8m)

Accounts Payable

22.0k452.0k(109.0k)(156.0k)(799.0k)451.0k1.3m1.4m4.0m2.1m467.0k2.7m(18.0k)(1.1m)(1.4m)257.0k(1.0m)190.0k229.0k(608.0k)(544.0k)2.5m1.5m1.9m2.1m5.4m2.0m2.2m

Cash From Operating Activities

(2.0m)(6.2m)(8.5m)(1.8m)(7.3m)(9.4m)(12.5m)(18.3m)(4.5m)(11.1m)(15.1m)(4.8m)(17.6m)(20.2m)(2.1m)13.8m16.5m(2.5m)(825.0k)1.7m(1.3m)3.5m4.9m(5.7m)(1.8m)(1.4m)(467.0k)

Purchases of PP&E

(96.0k)(426.0k)(510.0k)(164.0k)(393.0k)(885.0k)(717.0k)(1.2m)(3.0m)(11.3m)(16.6m)(1.8m)(2.8m)(3.2m)(282.0k)(481.0k)(841.0k)(569.0k)(1.3m)(1.6m)(596.0k)(994.0k)(2.3m)(543.0k)(1.1m)(2.1m)(2.0m)

Cash From Investing Activities

(217.0k)(638.0k)(895.0k)(324.0k)(784.0k)(1.5m)(411.0k)(1.1m)(1.6m)(5.2m)(13.9m)(19.0m)(2.4m)(3.6m)(4.1m)(452.0k)(856.0k)(1.3m)(977.0k)(1.7m)(2.2m)(624.0k)(1.4m)(5.9m)(4.1m)(2.8m)1.4m(109.4m)

Long-term Borrowings

(957.0k)(1.9m)(1.9m)(1.2m)(2.4m)(3.6m)(1.2m)(7.2m)(8.6m)(1.2m)(2.4m)(2.4m)

Cash From Financing Activities

3.8m10.2m10.7m(1.2m)1.8m45.2m1.4m92.4m98.0m(517.0k)(246.0k)934.0k19.0k2.7m2.7m84.0k5.7m27.3m312.0k1.9m1.9m(992.0k)358.0k21.0k(5.5m)(4.2m)(4.6m)(1.8m)

Net Change in Cash

1.5m3.4m1.3m(3.3m)(6.3m)34.4m78.8m78.1m(10.2m)(25.2m)(33.1m)(7.2m)(18.5m)(21.7m)(2.4m)18.6m42.5m(3.2m)(567.0k)1.4m(2.9m)2.5m(980.0k)(15.3m)(8.8m)(4.7m)(111.7m)

Cardiovascular Systems Ratios

USDQ1, 2012

Financial Leverage

2.1 x

Cardiovascular Systems Employee Rating

3.534 votes
Culture & Values
3.4
Work/Life Balance
3.7
Senior Management
3.2
Salary & Benefits
3.9
Career Opportunities
3.1
Source